Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Koki Ishibashi"'
Publikováno v:
Therapeutic Advances in Ophthalmology, Vol 13 (2021)
Objective: The purpose of our study was to determine the 4-year visual and anatomic outcomes of intravitreal aflibercept treatment for neovascular age-related macular degeneration (AMD) using a treat-and-extend (TAE) regimen. Methods: We retrospectiv
Externí odkaz:
https://doaj.org/article/be3bb66fd1284b3e94e14d4abdfd12a5
Autor:
Koki Ishibashi, Hiroyuki Yatsuka, Masatoshi Haruta, Kenichi Kimoto, Shigeo Yoshida, Toshiaki Kubota
Publikováno v:
Clinical Ophthalmology. 16:987-992
Koki Ishibashi,1,2 Hiroyuki Yatsuka,3 Masatoshi Haruta,1 Kenichi Kimoto,3 Shigeo Yoshida,1 Toshiaki Kubota3 1Department of Ophthalmology, Kurume University School of Medicine, Kurume, Japan; 2Department of Ophthalmology, Yame General Hospital, Yame,
Autor:
Kei Furushima, Shigeo Yoshida, Koki Ishibashi, Kenta Murotani, Yumi Ishibashi, Nobuhiro Kato, Yu Matsuo, Masatoshi Haruta
Publikováno v:
Clinical Ophthalmology (Auckland, N.Z.)
Yu Matsuo,1 Masatoshi Haruta,1 Yumi Ishibashi,1 Koki Ishibashi,1 Kei Furushima,1 Nobuhiro Kato,1 Kenta Murotani,2 Shigeo Yoshida1 1Department of Ophthalmology, Kurume University School of Medicine, Kurume, Japan; 2Biostatistics Center, Kurume Univers
Publikováno v:
Therapeutic Advances in Ophthalmology
Therapeutic Advances in Ophthalmology, Vol 13 (2021)
Therapeutic Advances in Ophthalmology, Vol 13 (2021)
Objective: The purpose of our study was to determine the 4-year visual and anatomic outcomes of intravitreal aflibercept treatment for neovascular age-related macular degeneration (AMD) using a treat-and-extend (TAE) regimen. Methods: We retrospectiv
Autor:
Rie Noda, Shotaro Dake, Yumi Ishibashi, Shigeo Yoshida, Kensuke Sasaki, Koki Ishibashi, Masatoshi Haruta, Yumiko Yoshida
Publikováno v:
Acta Ophthalmologica. 98
Autor:
KOKI ISHIBASHI, DAISHI KUROIWA
Publikováno v:
Journal of Nonlinear Analysis & Optimization: Theory & Applications; 2021, Vol. 12 Issue 1, p21-27, 7p
Autor:
Katsuyoshi Nakajima, Osamu Mukaiyama, Toshiyasu Takemoto, Yukiko Iio, Tetsuya Fukazawa, Koki Ishibashi, Yamaguchi Takeshi, Kazuhiro Itoh, Takahide Nishi
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 10:1665-1668
We report herein the synthesis and stereochemical structure–activity relationships of novel morpholine analogues 12 and 13 with regards to NK1, NK2 and NK3 tachykinin receptor binding affinity. An essential requirement for more potent binding affin
Autor:
Katsuyoshi Nakajima, Mitsuo Sugiyama, Hiroyoshi Horikoshi, Takahide Nishi, Yuki Sugioka, Koki Ishibashi, Hamada Takakazu
Publikováno v:
Chemical and Pharmaceutical Bulletin. 47:226-240
A series of 2-phenylbenzofuran derivatives with a carbamoyl, alkylamino, or alkyloxy group at the 5 or 6 position of the benzofuran ring were synthesized and evaluated for rat and human testosterone 5 alpha-reductase inhibitory activities in vitro. A
Publikováno v:
Tetrahedron: Asymmetry. 9:3251-3262
We report herein an efficient and practical synthetic method for the preparation of enantiomerically pure 2-[(2R)-arylmorpholin-2-yl]ethanols 1a–d, key intermediates of tachykinin receptor antagonist. Sharpless catalytic asymmetric dihydroxylation
Publikováno v:
Tetrahedron: Asymmetry. 9:2567-2570
We report simple and efficient methods for the preparation of enantiomerically pure spiro[benzo[ c ]thiophene-1(3 H ),4′-piperidine]-(2 S )-oxide ( S )- 1 , a key intermediate for the synthesis of tachykinin receptor antagonist, by resolution and a